Carticept Medical Closes $20M Series B Financing

Carticept Medical, Inc., an Alpharetta, Ga.-based developer of innovative products for the treatment of cartilage injuries and osteoarthritis, has completed a $20m Series B financing round.
New investor SonoSite, Inc. joined existing investors Domain Associates and New Enterprise Associates.
The financing will provide funding for the expected commercial launch of the NavigatorTM Delivery System, an integrated, computer-controlled, fluid delivery system designed to automate the delivery of medication for the benefit of both the patient and physician, as well to complete patient enrollment in the clinical study of the CartivaTM Synthetic Cartilage Implant.

Join the discussion